| Medical and Health Sciences | Lifetime | 965 | IT 28 | 99.96 |
| Pathology and Forensic Medicine | Lifetime | 62 | IT 4 | 99.75 |
| Rheumatology | Lifetime | 51 | IT 1 | 99.76 |
| Immunology | Lifetime | 621 | IT 23 | 98.14 |
| Dermatology | Lifetime | 362 | IT 15 | 97.43 |
| Endocrine and Autonomic Systems | Lifetime | 495 | IT 10 | 90.96 |
| Hematology | Lifetime | 890 | IT 48 | 90.93 |
| Behavioral Neuroscience | Lifetime | 541 | IT 6 | 78.58 |
| Pathology and Forensic Medicine | 2021-2025 | 35 | IT 4 | 99.19 |
| Rheumatology | 2021-2025 | 95 | IT 8 | 97.80 |
| Systemic Sclerosis and Related Diseases | Lifetime | 7 | IT 1 | 99.80 |
| Dermatologic Treatments and Research | Lifetime | 8 | IT 1 | 99.75 |
| Systemic Lupus Erythematosus Research | Lifetime | 37 | IT 5 | 99.76 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 54 | IT 1 | 99.72 |
| Skin Diseases and Diabetes | Lifetime | 13 | IT 1 | 99.11 |
| Urticaria and Related Conditions | Lifetime | 44 | IT 3 | 99.36 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 110 | IT 3 | 99.15 |
| Adrenal Hormones and Disorders | Lifetime | 65 | IT 5 | 98.96 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 103 | IT 7 | 99.15 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 55 | IT 3 | 99.06 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 875 | IT 26 | 98.64 |
| Mast cells and histamine | Lifetime | 152 | IT 6 | 97.87 |
| Vitamin D Research Studies | Lifetime | 231 | IT 6 | 98.19 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 131 | IT 7 | 97.97 |
| Circadian rhythm and melatonin | Lifetime | 317 | IT 5 | 97.80 |
| Autoimmune Bullous Skin Diseases | Lifetime | 255 | IT 19 | 98.07 |
| Connective Tissue Growth Factor Research | Lifetime | 41 | IT 2 | 97.47 |
| Estrogen and related hormone effects | Lifetime | 690 | IT 25 | 97.63 |
| Reproductive System and Pregnancy | Lifetime | 648 | IT 26 | 96.98 |
| Dermatological and Skeletal Disorders | Lifetime | 179 | IT 14 | 96.28 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 786 | IT 29 | 96.49 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 489 | IT 49 | 96.39 |
| Vasculitis and related conditions | Lifetime | 447 | IT 37 | 96.08 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 603 | IT 38 | 95.81 |
| Peripheral Neuropathies and Disorders | Lifetime | 531 | IT 51 | 96.05 |
| Spondyloarthritis Studies and Treatments | Lifetime | 509 | IT 47 | 95.36 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 848 | IT 22 | 93.85 |
| Lymphatic System and Diseases | Lifetime | 596 | IT 29 | 90.15 |
| Biosimilars and Bioanalytical Methods | Lifetime | 838 | IT 37 | 89.71 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 429 | IT 37 | 89.50 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 642 | IT 11 | 86.02 |
| Dupuytren's Contracture and Treatments | Lifetime | 251 | IT 4 | 86.76 |
| Macrophage Migration Inhibitory Factor | Lifetime | 804 | IT 20 | 82.26 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 182 | IT 11 | 67.24 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 10 | IT 2 | 99.39 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 46 | IT 5 | 98.92 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 45 | IT 4 | 97.21 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 190 | IT 17 | 96.95 |
| Vitamin D Research Studies | 2021-2025 | 103 | IT 11 | 93.33 |
| Dermatologic Treatments and Research | 2021-2025 | 123 | IT 14 | 94.21 |
| Skin Diseases and Diabetes | 2021-2025 | 31 | IT 2 | 88.19 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 485 | IT 43 | 92.31 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 269 | IT 22 | 90.79 |
| Vitamin C and Antioxidants Research | 2021-2025 | 150 | IT 14 | 83.49 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 519 | IT 75 | 85.44 |
| Vasculitis and related conditions | 2021-2025 | 567 | IT 52 | 83.75 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 443 | IT 30 | 78.73 |
| Mast cells and histamine | 2021-2025 | 364 | IT 26 | 79.58 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 247 | IT 31 | 78.13 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 641 | IT 66 | 78.07 |
| Dermatological and COVID-19 studies | 2021-2025 | 342 | IT 82 | 67.38 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 166 | IT 5 | 53.36 |
| Dermatological and Skeletal Disorders | 2021-2025 | 969 | IT 132 | 31.77 |
